Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at PLN 91.3B, ahead of BioNTech (PLN 85.8B) and Biogen (PLN 73.4B). Figures as of 18 Nov 2026, 15:49 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesPLN 91.3B
Median
PLN 8.1B
Combined market value
PLN 3.36T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CarePLN 91.3BPLN 837.7BPLN 675.42 1.34% down 33% up United States
2BioNTechBNTX · Health CarePLN 85.8BPLN 83.5BPLN 336.95 1.24% down 16% down Germany
3BiogenBIIB · Health CarePLN 73.4BPLN 148BPLN 1,001.46 0.68% down 49% up United States
4AmgenAMGN · Health CarePLN 34.8BPLN 970.1BPLN 1,793.51 2.59% down 34% up United States
5ModernaMRNA · Health CarePLN 34.8BPLN 325.2BPLN 803.66 3.35% down 755% up United States
6argenxARGX · Health CarePLN 29.4BPLN 239.9BPLN 3,814.52 0.13% up 4% up Belgium
7QiagenQGEN · Health CarePLN 15.2BPLN 41.1BPLN 199.27 0.38% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CarePLN 13.1BPLN 66BPLN 652.06 2.26% down 20% up United States
9VaxcytePCVX · Health CarePLN 10.8BPLN 36.9BPLN 233.18 2.37% down 22% up United States
10ExelixisEXEL · Health CarePLN 8.7BPLN 67.3BPLN 275.70 0.10% up 63% up United States
11Bio-TechneTECH · Health CarePLN 8.5BPLN 45.9BPLN 292.32 0.10% up 26% up United States
12RepligenRGEN · Health CarePLN 8.5BPLN 43.8BPLN 684.75 5.01% up 5% up United States
13CRISPR TherapeuticsCRSP · Health CarePLN 7.7BPLN 16.1BPLN 165.61 2.59% up 21% down Switzerland
14Revolution MedicinesRVMD · Health CarePLN 6.6BPLN 138.4BPLN 639.65 2.21% down 131% up United States
15Kymera TherapeuticsKYMR · Health CarePLN 6.4BPLN 41.6BPLN 486.93 0.34% down 87% up United States
16Krystal BiotechKRYS · Health CarePLN 4.9BPLN 36.5BPLN 1,230.82 2.54% up 46% up United States
17ImmunovantIMVT · Health CarePLN 3.4BPLN 27.9BPLN 134.69 0.87% up 43% up United States
18CG OncologyCGON · Health CarePLN 3BPLN 28.7BPLN 321.33 1.24% up 85% up United States
19Twist BioscienceTWST · Health CarePLN 1.9BPLN 31.1BPLN 456.43 1.36% up 340% up United States
20Scholar Rock HoldingSRRK · Health CarePLN 987MPLN 22.9BPLN 187.45 3.42% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CarePLN 879.7MPLN 18.5BPLN 114.31 0.21% down 88% up United States
22Kodiak SciencesKOD · Health CarePLN 632.8MPLN 25.5BPLN 390.65 0.37% up 396% up United States
23Halozyme TherapeuticsHALO · Health CarePLN 196.3MPLN 44.3BPLN 388.48 0.68% up 37% up United States
24ImmunityBioIBRX · Health Care-PLN 2BPLN 28BPLN 26.34 4.63% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0207 PLN).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (PLN 91.3B), BioNTech (PLN 85.8B) and Biogen (PLN 73.4B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 15:49 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of PLN 3.36T as of 18 Nov 2026, 15:49 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.